PET sheds light on Alzheimer's disease genetic risk.
Swerdlow
Russell H
RH
Departments of Neurology and Molecular and Integrative Physiology, University of Kansas School of Medicine, Kansas City, KS 66160, USA. rswerdlow@kumc.edu
D000375:Aging; D000465:Algorithms; D000544:Alzheimer Disease / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000235:genetics*; D002540:Cerebral Cortex / Q000000981:diagnostic imaging* / Q000378:metabolism; D005192:Family Health; D005220:Fathers; D005260:Female; D005462:Fluorine Radioisotopes / Q000493:pharmacokinetics; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D050259:Genes, Mitochondrial; D018740:Genetic Heterogeneity; D020022:Genetic Predisposition to Disease; D018392:Genomic Imprinting; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008136:Longevity / Q000235:genetics; D008297:Male; D009035:Mothers; D049268:Positron-Emission Tomography; D012306:Risk
D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D005947:Glucose